These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25205143)

  • 1. Incretin-based drugs and the risk of congestive heart failure.
    Yu OH; Filion KB; Azoulay L; Patenaude V; Majdan A; Suissa S
    Diabetes Care; 2015 Feb; 38(2):277-84. PubMed ID: 25205143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incretin based drugs and the risk of pancreatic cancer: international multicentre cohort study.
    Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Juurlink DN; Targownik LE; Turin TC; Paterson JM; Ernst P;
    BMJ; 2016 Feb; 352():i581. PubMed ID: 26888382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association Between Incretin-Based Drugs and the Risk of Acute Pancreatitis.
    Azoulay L; Filion KB; Platt RW; Dahl M; Dormuth CR; Clemens KK; Durand M; Hu N; Juurlink DN; Paterson JM; Targownik LE; Turin TC; Ernst P; ; Suissa S; Dormuth CR; Hemmelgarn BR; Teare GF; Caetano P; Chateau D; Henry DA; Paterson JM; LeLorier J; Levy AR; Ernst P; Platt RW; Sketris IS
    JAMA Intern Med; 2016 Oct; 176(10):1464-1473. PubMed ID: 27479930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Multicenter Observational Study of Incretin-based Drugs and Heart Failure.
    Filion KB; Azoulay L; Platt RW; Dahl M; Dormuth CR; Clemens KK; Hu N; Paterson JM; Targownik L; Turin TC; Udell JA; Ernst P;
    N Engl J Med; 2016 Mar; 374(12):1145-54. PubMed ID: 27007958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes.
    Abrahami D; Yin H; Yu OHY; Pollak MN; Azoulay L
    Epidemiology; 2018 Mar; 29(2):246-253. PubMed ID: 29283894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incretin-based therapy and risk of acute pancreatitis: a nationwide population-based case-control study.
    Thomsen RW; Pedersen L; Møller N; Kahlert J; Beck-Nielsen H; Sørensen HT
    Diabetes Care; 2015 Jun; 38(6):1089-98. PubMed ID: 25633664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study.
    Abrahami D; Douros A; Yin H; Yu OH; Faillie JL; Montastruc F; Platt RW; Bouganim N; Azoulay L
    BMJ; 2018 Dec; 363():k4880. PubMed ID: 30518618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus.
    Faillie JL; Yu OH; Yin H; Hillaire-Buys D; Barkun A; Azoulay L
    JAMA Intern Med; 2016 Oct; 176(10):1474-1481. PubMed ID: 27478902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of incretin agents and risk of pancreatic cancer: a population-based cohort study.
    Knapen LM; van Dalem J; Keulemans YC; van Erp NP; Bazelier MT; De Bruin ML; Leufkens HG; Croes S; Neef C; de Vries F; Driessen JH
    Diabetes Obes Metab; 2016 Mar; 18(3):258-65. PubMed ID: 26537555
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidiabetic therapy and the risk of heart failure in type 2 diabetic patients: an independent effect or confounding by indication.
    Koro CE; Bowlin SJ; Weiss SR
    Pharmacoepidemiol Drug Saf; 2005 Oct; 14(10):697-703. PubMed ID: 15654719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incretin-based drugs and hospitalization for heart failure in the clinical practice: A nested case-control study.
    Santucci C; Franchi M; Staszewsky L; La Vecchia C; Latini R; Merlino L; Corrao G; Bosetti C
    Diabetes Res Clin Pract; 2018 Dec; 146():172-179. PubMed ID: 30332619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of overall mortality and cardiovascular events in patients with type 2 diabetes on dual drug therapy including metformin: A large database study from the Cleveland Clinic.
    Kannan S; Pantalone KM; Matsuda S; Wells BJ; Karafa M; Zimmerman RS
    J Diabetes; 2016 Mar; 8(2):279-85. PubMed ID: 25929426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dipeptidyl peptidase-4 inhibitors and the risk of community-acquired pneumonia in patients with type 2 diabetes.
    Faillie JL; Filion KB; Patenaude V; Ernst P; Azoulay L
    Diabetes Obes Metab; 2015 Apr; 17(4):379-85. PubMed ID: 25581902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of incretin agents and risk of acute and chronic pancreatitis: A population-based cohort study.
    Knapen LM; de Jong RG; Driessen JH; Keulemans YC; van Erp NP; De Bruin ML; Leufkens HG; Croes S; de Vries F
    Diabetes Obes Metab; 2017 Mar; 19(3):401-411. PubMed ID: 27883260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study.
    Faillie JL; Azoulay L; Patenaude V; Hillaire-Buys D; Suissa S
    BMJ; 2014 Apr; 348():g2780. PubMed ID: 24764569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of incretin based drug treatments for type 2 diabetes.
    Bolen SD; Maruthur NM
    BMJ; 2016 Feb; 352():i801. PubMed ID: 26888024
    [No Abstract]   [Full Text] [Related]  

  • 17. Welcome reassurance about GLP-1 drugs--but they are still young and not fully grown.
    Riddle MC
    Diabetes Care; 2015 Feb; 38(2):183-5. PubMed ID: 25614687
    [No Abstract]   [Full Text] [Related]  

  • 18. The safety of incretin based drugs.
    Montori VM
    BMJ; 2014 Apr; 348():g2779. PubMed ID: 24764568
    [No Abstract]   [Full Text] [Related]  

  • 19. Risk of new-onset heart failure in patients using sitagliptin: a population-based cohort study.
    Eurich DT; Weir DL; Simpson SH; Senthilselvan A; McAlister FA
    Diabet Med; 2016 May; 33(5):621-30. PubMed ID: 26206341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatitis associated with the use of GLP-1 analogs and DPP-4 inhibitors: a case/non-case study from the French Pharmacovigilance Database.
    Faillie JL; Babai S; Crépin S; Bres V; Laroche ML; Le Louet H; Petit P; Montastruc JL; Hillaire-Buys D;
    Acta Diabetol; 2014; 51(3):491-7. PubMed ID: 24352344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.